Delve Insight
Delve Insight Market Research Reports
Title | published | price | |
---|---|---|---|
Malignant pleural mesothelioma (MPM) - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Malignant pleural mesothelioma (MPM) - Pipeline Insight, 2021," report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Malignant pleural mesothelioma (MPM) pipeline landscape. It covers the pipeline drug ... |
29-Jul-2021 | $2000 | |
Rheumatoid Arthritis (RA) - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Rheumatoid Arthritis (RA) - Pipeline Insight, 2021," report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Rheumatoid Arthritis (RA) pipeline landscape. It covers the pipeline drug profiles, including ... |
29-Jul-2021 | $3000 | |
Congenital Hyperinsulinism - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Congenital Hyperinsulinism - Pipeline Insight, 2021," report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Congenital Hyperinsulinism pipeline landscape. It covers the pipeline drug profiles, including c ... |
29-Jul-2021 | $1500 | |
Osteosarcoma - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Osteosarcoma - Pipeline Insight, 2021," report provides comprehensive insights about 38+ companies and 38+ pipeline drugs in Osteosarcoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical st ... |
29-Jul-2021 | $2000 | |
Chemotherapy Induced Peripheral Neuropathy - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Chemotherapy Induced Peripheral Neuropathy - Pipeline Insight, 2021," report provides comprehensive insights about 13+ companies and 13+ pipeline drugs in Chemotherapy Induced Peripheral Neuropathy pipeline landscape. It covers the p ... |
29-Jul-2021 | $1500 | |
Benign Prostatic Hyperplasia - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Benign Prostatic Hyperplasia - Pipeline Insight, 2021," report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Benign Prostatic Hyperplasia pipeline landscape. It covers the pipeline drug profiles, inclu ... |
29-Jul-2021 | $1500 | |
Cytomegalovirus infection - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Cytomegalovirus infection - Pipeline Insight, 2021," report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Cytomegalovirus infection pipeline landscape. It covers the pipeline drug profiles, including c ... |
29-Jul-2021 | $2000 | |
Essential thrombocythemia - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Essential thrombocythemia - Pipeline Insight, 2021," report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in Essential thrombocythemia pipeline landscape. It covers the pipeline drug profiles, including cli ... |
29-Jul-2021 | $1500 | |
Vernal Keratoconjunctivitis - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Vernal Keratoconjunctivitis - Pipeline Insight, 2021," report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Vernal Keratoconjunctivitis pipeline landscape. It covers the pipeline drug profiles, including ... |
29-Jul-2021 | $1500 | |
Aneurysmal Subarachnoid Hemorrhage - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Aneurysmal Subarachnoid Hemorrhage - Pipeline Insight, 2021," report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Aneurysmal Subarachnoid Hemorrhage pipeline landscape. It covers the pipeline drug profi ... |
29-Jul-2021 | $1500 | |
Cancer Cachexia - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Cancer Cachexia - Pipeline Insight, 2021," report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Cancer Cachexia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclini ... |
29-Jul-2021 | $1500 | |
Hunter Syndrome - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Hunter Syndrome - Pipeline Insight, 2021," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Hunter Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclini ... |
29-Jul-2021 | $1500 | |
Uveitis - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Uveitis - Pipeline Insight, 2021," report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Uveitis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage produc ... |
29-Jul-2021 | $1500 | |
Gastroparesis - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Gastroparesis - Pipeline Insight, 2021," report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Gastroparesis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical ... |
29-Jul-2021 | $1500 | |
Celiac Disease - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Celiac Disease - Pipeline Insight, 2021," report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Celiac Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinica ... |
29-Jul-2021 | $2000 | |
Schizophrenia - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Schizophrenia - Pipeline Insight, 2021," report provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Schizophrenia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical ... |
29-Jul-2021 | $2500 | |
AL Amyloidosis - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "AL Amyloidosis - Pipeline Insight, 2021," report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in AL Amyloidosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinica ... |
29-Jul-2021 | $1500 | |
Epilepsy - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Epilepsy - Pipeline Insight, 2021," report provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Epilepsy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage prod ... |
29-Jul-2021 | $2500 | |
Alcoholic Hepatitis - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Alcoholic Hepatitis - Pipeline Insight, 2021," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Alcoholic Hepatitis pipeline landscape. It covers the pipeline drug profiles, including clinical and ... |
29-Jul-2021 | $1500 | |
Diabetic macular edema - Pipeline Insight, 2021By Delve Insight
DelveInsight's, "Diabetic macular edema - Pipeline Insight, 2021," report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Diabetic macular edema pipeline landscape. It covers the pipeline drug profiles, including clinica ... |
29-Jul-2021 | $2500 | |